Not all marketed skin cleansers’ pH is optimal for atopic dermatitis

2024-7-1

What can be learned from real-world data about chronic spontaneous urticaria?

2024-7-1

Fruit allergy and anaphylaxis in children: Culprit fruits and clinical findings

2024-7-1

The long-term outcomes of mepolizumab treatment at 100 mg dose on idiopathic chronic eosinophilic pneumonia: A real-life experience

2024-7-1

Leveraging advanced sensors in pollen research

2024-7-1

Clinical features, severity, and immunological changes during venom immunotherapy in children and adults

2024-7-1

Association of serum pertussis antibodies with acute asthma attacks in children

2024-7-1

Physician- and patient-reported outcomes by hereditary angioedema type: Data from a real-world study

2024-7-1

Evaluation of atopic diseases in patients with allergic contact dermatitis

2024-7-1

Early testing and grade of the reaction are affecting factors of skin test positivity in β-Lactam allergies

2024-7-1

Perspectives on allergic diseases: From asthma to food allergy ‐ A continuing challenge for the Allergist-Immunologist

2024-7-1

For the patient

2024-7-1

Sleep quality in patients with chronic spontaneous urticaria and relation with Orexin-A, leptin, and ghrelin

2024-7-1

Real-world effectiveness of dupilumab versus benralizumab and mepolizumab

2024-7-1

Consistent efficacy and safety of sublingual immunotherapy tablets across allergens and geographic regions

2024-7-1

Assessment of clinical phenotypic characteristics of patients with angioedema without wheals in a turkish population

2024-7-1

Efficacy and safety of hymenoptera venom immunotherapy

2024-7-1

Successful rapid liposomal amphotericin B desensitization in pediatric case series

2024-5-1

Comparison of clinical traits for seasonal and perennial allergic rhinitis during allergen exposure

2024-5-1

For the patient

2024-5-1

Evaluation of sinonasal involvement in patients with asthma and chronic obstructive pulmonary disease

2024-5-1

Removing penicillin allergy label in a hospitalized adolescent with a remote penicillin and recent cephalosporin allergy

2024-5-1

Metal implant allergy: A retrospective cohort analysis at a university allergy practice

2024-5-1

Abstracts Presented at the Western Society of Allergy, Asthma & Immunology, February 4‐8, 2024, Koloa, Hawaii

2024-5-1

Hereditary angioedema with normal C1 esterase inhibitor: Current paradigms and clinical dilemmas

2024-5-1

Allergen skin test responses in broad U.S. asthma population in those with and without rhinitis

2024-5-1

Relationships between bronchiectasis and time to achieving target trough immunoglobulin G levels in patients with common variable immunodeficiency

2024-5-1

Hymenoptera venom immunotherapy: Safety and efficacy of an accelerated induction regimen with depot aluminum adsorbed extracts

2024-5-1

Exploring the spectrum of allergic disorders that continue to challenge the Allergist-Immunologist: From hereditary angioedema to metal implant allergy

2024-5-1

Addressing global health disparities in the management of RSV infection in infants and children: Strategies for preventing bronchiolitis and post-bronchiolitis recurrent wheezing

2024-3-1

Impact of steroids on the immune profiles of children with asthma living in the inner-city

2024-3-1

Assessing severity of COVID-19 and the development of multi system inflammatory syndrome in children (MIS-C) in pediatric patients with atopic disease

2024-3-1

Understanding of lipid transfer protein sensitization patterns and its clinical significance in children

2024-3-1

Initial updosing phase of oral immunotherapy improves quality of life and psychological burden in parents of children with food allergy

2024-3-1

Factors influencing the quality of life in children with atopic dermatitis in Korea: A multicenter cross-sectional study

2024-3-1

For the Patient

2024-3-1

Oral immunotherapy with sunflower seed butter and a review of seed allergy

2024-3-1

Total IgE as a biomarker of omalizumab response in chronic spontaneous urticaria: A meta-analysis

2024-3-1

The relationship between childhood atopic dermatitis and asthma in an under resourced community

2024-3-1

Allergic diseases in children: A continuing challenge for the Allergist-Immunologist

2024-3-1

Real-world reporting rates of administration-site reactions with on-demand treatment of hereditary angioedema attacks

2024-1-22

Markers of eosinophilic airway inflammation in patients with asthma and allergic rhinitis

2024-1-1

Risk of asthma and/or wheezing in obese individuals with or without metabolic syndrome: From the Korea National Health and Nutrition Examination Survey data

2024-1-1

Evaluation of different protocols for classification of pediatric hypersensitivity reactions to nonsteroidal anti-inflammatory drugs: Children with underlying allergic disease should be a separate subgroup

2024-1-1

A case-control study for comorbidity and laboratory factors associated with food-induced anaphylaxis

2024-1-1

Assessment of mask use on oxygen saturation in adults and children with asthma

2024-1-1

Protective antibody concentrations in primary immunodeficiency following infusion with 5% or 10% intravenous immunoglobulin

2024-1-1

An expert panel's review on patients with hereditary angioedema switching from attenuated androgens to oral prophylactic therapy

2024-1-1

Inpatient allergy delabeling of pediatric patients with low-risk penicillin allergy status through direct oral amoxicillin challenge

2024-1-1

Real-world effectiveness and predictors of super-responders to dupilumab in a Chinese uncontrolled asthma cohort

2024-1-1